Health TED Talks
Will the next generation think about diseases like Alzheimers and diabetes the way we think about polio and the whooping cough? Susan Solomon, the co-founder of the New York Stem Cell Foundation (NYSCF), certainly hopes so. In this fascinating talk from TEDGlobal 2012, Solomon delves into the foundations work on research with stem cells, which she calls the black boxes for diseases.
[Stem cells] are our bodies own repair kits. They are pluripotent, which means they can morph into all of the cells in our bodies, says Solomon. Right now there are some really extraordinary things that we are doing with stem cells that are completely changing the way we model disease, our ability to understand why we get sick and even develop drugs. But this field has been under siege, politically and financially.
While much of the fray is about embryonic stem cells still the gold standard when it comes to cells Solomon explains that another type of pluripotent stem cell (called iPS cells) can now be created by, essentially, reprogramming skin cells. These cells hold great promise for allowing researchers to see how diseases develop in humans, rather than in rodents.
Currently, developing a drug takes an average of 13 years, costs $4 billion, and has a 99% failure rate. And because its impossible to test a new drug on a large and representative sample of the human population, even a drug that tests well with many people will have side-effects for others, based on their genetic makeup. This is a problem thats sometimes not apparent until the drug is on the market and being prescribed to patients like in the tragic case of Vioxx.
Thats a terrible business model, but also is a horrible social model,she says. The way weve been developing drugs is essentially like going into a shoe store and no one asking what size you are They just say, Well, you have feet. Here are shoes.
From the TEDGlobal stage, Solomon outlined an exciting new approachher team at NYSCF has developed a machine that creates stem cell lines that, until now, had to be crafted by hand. NYSCF expects to produce 2,500 stem cell lines by the end of the year. The idea is to eventually produce a comprehensive array of 25,000 stem cell lines which act like avatars for a wide sample of people that researchers would have access to as they test new drugs.This could help avoid disasters and also let people know ahead of time of what side-effects they, specifically, can expect with a given medicine.
Two months after her talk, Solomon tells the TED Blog that interest in NYSCF work is growing. Pointing to a recent article in The New York Times about how future lung cancer treatments could be tailored to individuals, Solomon said, Its really the leading edge of where this field is going.
But Solomon stressed that it will be extremely difficult to change the current systems of drug development.
All the established companies have been using mouse-and-rodent testing forever, she said. A lot of peoples careers are staked to a method that is outdated. Its like the tech sector; this is really the high-tech sector for biomedical research.
To hear more about the NYSCF, watch Solomons talk. Below, watch 9 more talks about the incredible promise of stem cells.
Susan Lim: Transplant cells, not organsAs a woman, surgeon Susan Lim had to fight for the right to perform the first liver transplant in Asia. But she began to question the morality of such work given that with donor organs in such short supply many are coerced or forced to donate. Lim began looking at another approach: transplanting cells, rather than organs. In this talk, given at the INK Conference, she describes her work with adult stem cells derived from fat.
Daniel Kraft invents a better way to harvest bone marrowPediatrician and stem cell researcher Daniel Kraft has created a device to collect bone marrow in a way that is far less painful for both the patient and the doctor. In this talk from TED2009, Kraft shows how the stem cells found in this marrow could be used to treat heart disease and Parkinsons.
Eva Vertes: Do stem cells cause cancer?Microbiology prodigy Eva Vertes was 19 years old when she spoke at TED2005 about a theory that cancer might be a repair response to damaged stem cells in the lungs, liver, bones, etc. The implication she is testing? Its possible, although far-fetched, that in the future we could think of cancer being used as a therapy.
Alan Russell: The potential of regenerative medicineNot for the squeamish, in this talk from TED2006, medical futurist Alan Russell shows a video of stem cells being removed from a patients hip and injected directly into their heart and how this procedure has gotten much more precise over a short time. Such cell regeneration therapies will keep improving, Russell says.
Noel Bairey Merz: The single biggest health threat women faceWhile heart disease is often thought of as a male disease, Noel Bairey Merz explains that it is actually the biggest killer of women. In this talk from TEDxWomen 2011, Merz gives a call to arms for women to think of heart disease in the same way we do breast cancer, and talks about some exciting possibilities for treatment, including stem cell therapy.
Daniel Kraft: Medicines future? Theres an app for thatKraft, chair of the FutureMed program at Singularity University, talks about some of the big innovations coming down the pipeline in medicine. Near the end of this talk given at TEDxMaastricht, Kraft talks about cancer stem cells and how understanding them could lead to an era of personalized oncology the ability to leverage all of this data together, analyze the tumor and come up with a real, specific cocktail for the individual patient.
Juan Enriquez: The next species of humanFuturist Juan Enriquez believes that some big changes are coming, and that the next generation of humans could potentially be considered a different species. Why? In this talk from TED2009, he looks at the ability to engineer both cells and tissue, and describes some shocking ways researchers are using stem cells.
Kevin Stone: The bio-future of joint replacementArthritis affects more adults than cancer, says Kevin Stone in this talk from TED2010. While therapies using human tissue have been very promising in helping joint damage, there simply isnt enough donor tissue to go around. Stone explains a process which uses cartilage from a pig, loaded with a persons own stem cells, to ease pain and immobility.
Iain Hutchison: Saving facesIn this talk from TEDGlobal 2010 which contains some images of badly injured and disfigured faces that may be disturbing facial surgeon Iain Hutchison gives a look at his groundbreaking work. Towards the end of the talk, he describes an promising area of research tissue engineering which uses a patients own stem cells, taken from their hip, to help heal facial damage.
See the original post here:
10 talks on the future of stem cell medicine | TED Blog
- Regenerative Medicine Market trends, leaders, segment analysis and forecast to 2030 described in a new market report - WhaTech Technology and Markets... - February 16th, 2020
- 5 Aesthetic Clinics To Know In The Klang Valley & Their Signature Treatments - Malaysia Tatler - February 14th, 2020
- Tech Ventures kicks off series dedicated to supporting female inventors and entrepreneurs at Johns Hopkins - The Hub at Johns Hopkins - February 14th, 2020
- BrainStorm Cell Therapeutics to Announce Fourth Quarter and Full Year 2019 Financial Results and Provide a Corporate Update - GlobeNewswire - February 11th, 2020
- CD229 CAR T-cell therapy treated tumours had lasting response mice - Drug Target Review - February 11th, 2020
- BrainStorm Cell Therapeutics to Announce Fourth Quarter and Full Year 2019 Financial Results and Provide a Corporate Update - BioSpace - February 11th, 2020
- Early Findings Show Promise of CAR NK-Cell Therapy in Leukemia, Lymphoma - Cancer Network - February 9th, 2020
- Physical forces at the interface with biology and chemistry - PLoS Blogs - February 9th, 2020
- Scientists create 'Chemical gardens' that can be used as bone substitute materials - University of Birmingham - February 7th, 2020
- Lab-grown heart cells implanted into human patient for the first time - New Atlas - January 29th, 2020
- Engineer the future of human health with a PhD in biomedical engineering - Study International News - January 29th, 2020
- GIOSTAR Announces Medical Breakthrough in Biotechnology and Lifesciences To Manufacture Abundant, Safe Red Blood Cells From Stem Cells - Benzinga - January 29th, 2020
- Study suggests Parkinson's present from birth and may be preventable - New Atlas - January 29th, 2020
- Celavie Biosciences Presented Five-Year Follow-Up Data in Parkinsonian Patients at the World Stem Cell Summit - Yahoo Finance - January 22nd, 2020
- The Brave New World of Organoids - North Forty News - January 22nd, 2020
- The Tiny Brain Cells That Connect Our Mental and Physical Health - WIRED - January 22nd, 2020
- Organicell Regenerative Medicine Inc. Provides Update On Operations and Financial Reporting Status - GlobeNewswire - January 22nd, 2020
- Novel mutations in stem cells of young donors can be passed to recipients - BioNews - January 21st, 2020
- Gains in Stem Cell Transplant Mortality Over Last 25 Years - MedPage Today - January 21st, 2020
- Biomedical Applications of Zeolitic Nanoparticles, with an Emphasis on | IJN - Dove Medical Press - January 21st, 2020
- Cell therapy trialed in mice offers diabetes treatment hope - SelectScience - January 21st, 2020
- Scientists Image Heart RNA Structure for the First Time - Diagnostic and Interventional Cardiology - January 21st, 2020
- CAR T-Cell Therapy and Beyond: Off-the-Shelf Therapies Among Innovations at ASH 2019 - AJMC.com Managed Markets Network - January 21st, 2020
- Stem Cell Assay Market to Expand at a Healthy CAGR of XX% Between and 2017 2025 Dagoretti News - Dagoretti News - January 21st, 2020
- Introducing Generate Life Sciences - A First-Of-Its-Kind Company Focused On Helping Grow And Protect Healthy Families - Yahoo Finance - January 19th, 2020
- Editas Medicine and Sandhill Therapeutics, Inc. Announce Collaboration to Develop Engineered Cell Medicines to Treat Cancer - Yahoo Finance - January 19th, 2020
- Regenerative Medicine Market 2026: Product Approvals and Growing Pipeline of Regenerative Medicine P - PharmiWeb.com - January 18th, 2020
- Mutations in donors' stem cells may cause problems for cancer patients - Washington University School of Medicine in St. Louis - January 18th, 2020
- Global Cell Expansion Market by Type, Share Analysis, Top Players Eyeing to Penetrate Into Emerging Nations with Untapped Opportunities 2024 ... - January 18th, 2020
- Introducing Generate Life Sciences - A First-Of-Its-Kind Company Focused On Helping Grow And Protect Healthy Families - PRNewswire - January 18th, 2020
- Stem Cell and Regenerative Medicine Action Awards to be Presented at World Stem Cell Summit on January 23 at the Hyatt Regency Miami - GlobeNewswire - January 12th, 2020
- SNACS: The FAANG Of The Roaring 20s - Yahoo Finance - January 12th, 2020
- 20 Technology Metatrends That Will Define the Next Decade - Singularity Hub - January 12th, 2020
- LANL Scientists And International Partners Create 3-D Image Of Heart RNA Structure For First Time - My Blog - Los Alamos Daily Post - January 12th, 2020
- MicroCures Awarded $1.5M SBIR Grant To Support Development of Novel Therapeutic Platform for Accelerated Tissue Repair - BioSpace - January 8th, 2020
- 2020 Exosome Technologies Market Top Companies Analysis Including Capricor Therapeutics Inc, Evox Therapeutics Ltd, ReNeuron Group Plc, Stem Cell... - January 8th, 2020
- Gene editing breakthroughs that cured genetic diseases in 2019 - The Star Online - January 5th, 2020
- BrainStorm Cell Therapeutics Wins 2020 'Buzz of BIO' Award for ALS Investigational Therapy - ALS News Today - January 3rd, 2020
- Cell and Advanced Therapies Supply Chain Management Industry Report, 2019-2030 - GlobeNewswire - January 3rd, 2020
- miRNAs: A Promising Target in the Chemoresistance of Bladder Cancer | OTT - Dove Medical Press - January 3rd, 2020
- China confirms third birth of gene-edited baby; scientists involved get prison terms - WRAL Tech Wire - January 3rd, 2020
- Gene Therapies Make it to Clinical Trials - Discover Magazine - December 31st, 2019
- What is HLH, and what role did it play in the death of a healthy 34-year-old ESPN reporter? - FirstCoastNews.com WTLV-WJXX - December 29th, 2019
- 2019: The year gene therapy came of age - INQUIRER.net - December 29th, 2019
- Stem Cells Market is Expected to Expand at an Impressive Rate by 2023 - News Cast Report - December 29th, 2019
- ESPN reporter diagnosed with pneumonia, HLH. What is HLH? - Crossroads Today - December 27th, 2019
- 2019: the year gene therapy came of age - Times of India - December 27th, 2019
- This Is How Human Head Transplants Could Be Achieved, According To A Neurosurgeon - IFLScience - December 25th, 2019
- Taiwan Healthcare+ Expo 2019: A 360 exposure to MedTech and Therapeutic world - BSA bureau - December 22nd, 2019
- Lawmakers Present Mother & Daughter With the Signed Bill They Inspired - River Journal Staff - December 22nd, 2019
- Sorrento Announces Dr. Robin Smith as New Member of the Board of Directors - GlobeNewswire - December 22nd, 2019
- Association Between Change in Circulating Progenitor Cells During Exercise Stress and Risk of Adverse Cardiovascular Events in Patients With Coronary... - December 20th, 2019
- The Most Significant Cancer Research Advances of the 2010s - Dana-Farber Cancer Institute - December 20th, 2019
- Metabolic dysregulation: origins of neurodegenerative disease - Health Europa - December 20th, 2019
- Inside the US-Iran prisoner swap, and what comes next - Al-Monitor - December 20th, 2019
- Global Stem Cell Therapy Market to Surpass US$ 40.3 Billion by 2027 Coherent Market Insights - Business Wire - December 18th, 2019
- The 3D cell culture market is projected to reach USD 1,846 million by 2024 from USD 892 million in 2019, at a CAGR of 15.7% - PRNewswire - December 18th, 2019
- Orthopaedic Surgeon, Dr. Jeffrey Carlson, first in Central and Eastern Virginia to implant the M6-C Artificial Cervical Disc - BioSpace - December 18th, 2019
- Gene Therapy for Sickle-Cell Anemia Looks Promisingbut It's Riddled With Controversy - Singularity Hub - December 18th, 2019
- Orbiting Organoids: Research in Space to Unveil New Neurodegeneration Insight - Xconomy - December 18th, 2019
- Dr. Jack Zamora Partners with the Exclusive Haute Beauty Network - PR Web - December 18th, 2019
- Global Stem Cell Assay Market Mainstream Connectivity 2019: Regenerative Medicine & Therapy Development, Drug Discovery and Development, Clinical... - December 18th, 2019
- Stem Cell Banking Market to Surge at a Robust Pace in Terms of Revenue Over 2018 2028 - Montana Ledger - December 18th, 2019
- RoosterBio Expands Facility for Second Time in 2019 December 18, 2019Project will support the increasing - PR Web - December 18th, 2019
- By turning stem cells into brain cells, Aspen Neuroscience hopes to rewind the progress of Parkinson's disease - FierceBiotech - December 14th, 2019
- SelectScience Interview: Regenerative medicine technique development and the importance of cooperative research - SelectScience - December 14th, 2019
- Mechanism may have therapeutic bone healing applications - Baylor College of Medicine News - December 14th, 2019
- CHMP Grants Positive Opinion for Expanded Use of Darzalex (daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone (VTd) for... - December 14th, 2019
- Mayo Clinic, maker of Gore-Tex outerwear are teaming up in Crohn's fight - Minneapolis Star Tribune - December 11th, 2019
- Proteostasis Therapeutics to Initiate First Ever Personalized Medicine-Based Clinical Trial, CHOICES, in European CF Patients with Genotypes... - December 11th, 2019
- Stem Cell and Regenerative Therapy Market 2019 By Global Industry Size, Share, Growth, Trends, Top Company Profiles and Future Analysis 2026 - Montana... - December 11th, 2019
- Blinatumomab Instead of Chemo in Young Patients With Relapsed ALL - Medscape - December 10th, 2019
- Fate Therapeutics Soars as Much as 45.8% After Giving Investors What They Wanted - The Motley Fool - December 10th, 2019
- FDA Warns Liveyon Over Cord Blood Stem Cell Products - MedPage Today - December 10th, 2019
- Gamida Cell Announces Results from Phase 1 Study of GDA-201 and New Mechanism of Action Data at ASH 2019 Annual Meeting - Business Wire - December 10th, 2019
- AgeX Therapeutics Issues Year-End Letter to Shareholders - BioSpace - December 10th, 2019
- Jasper Therapeutics Announces Upcoming Data Presentation on Lead Program, JSP191, at 61st American Society of Hematology (ASH) Annual Meeting &... - December 10th, 2019
- The Uncertainty of Regulating 3D Organ Printing - The Regulatory Review - December 10th, 2019
- Top Florida Medical Spa, Amnion of Florida, Partners With Merakris Therapeutics to Advance Their Non-Surgical Treatment Options - Business Wire - December 10th, 2019
- Mustang Bio Announces Updated Clinical Data on MB-107 Lentiviral Gene Therapy for Patients with X-Linked Severe Combined Immunodeficiency -... - December 10th, 2019